Disclosures for "Postinfectious Paraneoplastic Glial Fibrillary Acidic Protein (GFAP) Encephalitis in an Adolescent: Complexities in the Appropriate Diagnosis and Treatment"
-
Dr. Heller has nothing to disclose.
-
Dr. Shelton has nothing to disclose.
-
Author has nothing to disclose
-
Dr. Linnoila has received research support from NIH/NINDS. Dr. Linnoila has received personal compensation in the range of $10,000-$49,999 for serving as a expert respondent on autoimmune encephalitis with U.S. government/DHHS/vaccine injury compensation program.